Veeva SystemsWBO:VEEV +0.03%92 FCF Yield % is 5.78 as of Jul. 01, 2026, which is 152% above its 10-year median of 2.29. GuruFocus rates WBO:VEEV with a GF Score™ of 92/100 and a GF Value™ of €246.74 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 685 Healthcare Providers & Services companies, Veeva Systems ranks better than 68.61% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Veeva Systems's FCF Yield % or its related term are showing as below:
WBO:VEEV'
s FCF Yield % Range Over the Past 10 Years
Min: 0.85 Med: 2.29 Max: 6.54
Current: 5.78
During the past 13 years, the highest FCF Yield % of Veeva Systems was 6.54%. The lowest was 0.85%. And the median was 2.29%.
WBO:VEEV's FCF Yield % is ranked better than 68.61% of 685
companies
in the Healthcare Providers & Services industry
Industry Median: 1.84
vs WBO:VEEV: 5.78
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Veeva Systems FCF Yield % Related Terms
Veeva Systems FCF Yield % Historical Data
* Premium members only.
The historical data trend for Veeva Systems's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WBO:VEEV vs BTSG, TEM, HQY: FCF Yield % Comparison
For the Health Information Services subindustry, Veeva Systems's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Veeva Systems FCF Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Veeva Systems's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Veeva Systems's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Veeva Systems (WBO:VEEV) has a FCF Yield % of 5.78 as of Jul. 01, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Veeva Systems and its competitors. This is 152% above median its historical median of 2.29. Over the past decade, Veeva Systems' FCF Yield % has ranged from 0.85 to 6.54. According to the industry distribution chart, Veeva Systems ranks #215 out of 685 companies in the Healthcare Providers & Services industry, placing it in the top 31.4%.
Is Veeva Systems' FCF Yield % too high?
Veeva Systems' current FCF Yield % of 5.78 is 152% above median its 10-year median of 2.29. Over the past 10 years, this metric has ranged from a low of 0.85 to a high of 6.54. The Healthcare Providers & Services industry median FCF Yield % is 1.84. Veeva Systems' value of 5.78 is 214.1% above this industry median. Based on the distribution chart, Veeva Systems ranks #215 out of 685 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Veeva Systems has a GF Score™ of 92/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Veeva Systems' FCF Yield % compare to BTSG and TEM?
According to the Healthcare Providers & Services industry distribution chart, Veeva Systems ranks #215 out of 685 companies for FCF Yield %. This puts Veeva Systems in the upper half of its industry. The industry median FCF Yield % is 1.84. Veeva Systems' value of 5.78 is 214.1% above this benchmark. Historically, Veeva Systems' own FCF Yield % has ranged from 0.85 to 6.54 over the past decade. While the company's 10-year median is 2.29 vs. the industry median of 1.84, Veeva Systems has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Healthcare Providers & Services company?
The median FCF Yield % among Healthcare Providers & Services companies is 1.84, based on 685 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Veeva Systems's current FCF Yield % of 5.78 is 214.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Veeva Systems and its competitors. For the Healthcare Providers & Services industry, the median FCF Yield % is 1.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Veeva Systems's current FCF Yield % is 5.78, which is 152% above median its own 10-year median of 2.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Veeva Systems stock overvalued right now?
Based on GuruFocus' analysis, Veeva Systems (WBO:VEEV) is currently considered Significantly Undervalued. The stock's GF Value™ is €246.74, compared to a current price of €153.25 — trading 37.9% below its estimated fair value. The current FCF Yield % is 5.78, which is 152% above median its 10-year median of 2.29 and 214.1% above the Healthcare Providers & Services industry median of 1.84. Veeva Systems' overall GF Score™ is 92/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Veeva Systems (WBO:VEEV), the current FCF Yield % is 5.78 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Veeva Systems (WBO:VEEV) Overvalued in 2026?
Based on GuruFocus' analysis, Veeva Systems stock appears to be undervalued.
The current stock price of €153.25 is trading 37.9% below its estimated GF Value™ of €246.74.
GuruFocus considers Veeva Systems to be Significantly Undervalued.
Key valuation signals for WBO:VEEV:
FCF Yield %: 5.78 (152% above median its 10-year median of 2.29)
GF Value™: €246.74 vs. price of €153.25 (37.9% below fair value)
Industry Position: 214.1% above the Healthcare Providers & Services median (#215 of 685)
No single metric tells the full story. See the WBO:VEEV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
92GF Score
Get the complete analysis for WBO:VEEV
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:VEEV has been successfully added to your 
